GILLIS STEVEN — SEC insider filings

SEC reporting owner CIK 1229592. 50 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2020-09-01 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Prime Medicine, Inc. (PRME)10% owner34 legs · 7,030,300 sh · $43,599,990—6
Metsera, Inc. (MTSR)Director, 10% owner22 legs · 2,222,222 sh · $39,999,996—9
Lyell Immunopharma, Inc. (LYEL)10% owner22 legs · 2,809,352 sh · $37,499,977——
Neumora Therapeutics, Inc. (NMRA)10% owner920 legs · 3,922,764 sh · $36,430,001—12
Kardigan, Inc. (KARD)Director, 10% owner21 leg · 1,250,000 sh · $20,000,000—4
Aspen Neuroscience, Inc. (ASPE)10% owner23 legs · 1,333,333 sh · $19,999,995—18
Seaport Therapeutics, Inc. (SPTX)10% owner11 leg · 1,100,000 sh · $19,800,000—4
DA32 Life Science Tech Acquisition Corp. (DALS)10% owner31 leg · 1,600,000 sh · $16,000,000—3
Sana Biotechnology, Inc. (SANA)10% owner23 legs · 1,818,181 sh · $9,999,996—14
Codiak BioSciences, Inc. (CDAK)Director72 legs · 5,235,000 sh · $3,525,000—12

+9 more issuers among the filings shown — every filing appears in the table below.

Insider filings — GILLIS STEVEN

FiledFormIssuerReported transactionsSource
2026-11-054Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, NELSEN ROBERT, Burow Kristina, BERNS PAUL L, BYBEE CLINTON
Purchase (P): 2,321,262 @ $10.77EDGAR
2026-11-024Aspen Neuroscience, Inc. (ASPE)
jointly with ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, LLC, CRANDELL KEITH, Burow Kristina, NELSEN ROBERT
Purchase (P): 66,666 @ $15 · Conversion (C): 187,182 · Conversion (C): 298,258 · Conversion (C): 286,304 · Conversion (C): 295,490 · Conversion (C): 259,948 · +15 moreEDGAR
2026-10-293Aspen Neuroscience, Inc. (ASPE)
jointly with ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, LLC, CRANDELL KEITH, Burow Kristina, NELSEN ROBERT
Holdings only — no transactions reportedEDGAR
2026-10-194CITY THERAPEUTICS, INC. (CTY)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, Burow Kristina
Conversion (C): 3,294,900 · Conversion (C): 5,482,309 · Conversion (C): 2,027,006 · Purchase (P): 170,000 @ $18 · Conversion (C): 3,000,000 (derivative) @ $0 · Conversion (C): 4,991,633 (derivative) @ $0 · +1 moreEDGAR
2026-10-153CITY THERAPEUTICS, INC. (CTY)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, Burow Kristina
Holdings only — no transactions reportedEDGAR
2026-07-064Boundless Bio, Inc. (BOLD)
jointly with CRANDELL KEITH, BYBEE CLINTON, NELSEN ROBERT, Burow Kristina
Option exercise (M): 16,000 @ $1.03 · Sale (S): 16,000 @ $2.49 · Option exercise (M): 16,000 (derivative) @ $0EDGAR
2026-07-064TAKEDA PHARMACEUTICAL CO LTD (TAK)Grant/award (A): 3,800 @ $0 · Disposition to issuer (D): 1,152 (derivative) @ $4,931.20 · Grant/award (A): 1,319 (derivative) @ $0EDGAR
2026-06-244Kardigan, Inc. (KARD)
jointly with ARCH Venture Partners XIII, LLC, ARCH Venture Partners XIII, L.P., ARCH Venture Fund XIII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina
Purchase (P): 1,250,000 @ $16EDGAR
2026-06-224Kardigan, Inc. (KARD)
jointly with ARCH Venture Partners XIII, LLC, ARCH Venture Partners XIII, L.P., ARCH Venture Fund XIII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina
Conversion (C): 13,792,035 · Conversion (C): 5,148,587 (derivative) · Conversion (C): 1,204,000 (derivative) · Conversion (C): 2,306,401 (derivative)EDGAR
2026-05-044Seaport Therapeutics, Inc. (SPTX)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina
Conversion (C): 2,513,686 · Conversion (C): 2,681,265 · Purchase (P): 1,100,000 @ $18 · Conversion (C): 2,513,686 (derivative) @ $0 · Conversion (C): 2,681,265 (derivative) @ $0EDGAR
2026-03-094Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, NELSEN ROBERT, Burow Kristina, BERNS PAUL L, BYBEE CLINTON
Purchase (P): 488,090 @ $25.61EDGAR
2025-11-144Metsera, Inc. (MTSR)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, NELSEN ROBERT
Disposition to issuer (D): 18,503,128 · Disposition to issuer (D): 8,313,680EDGAR
2025-10-294Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, BYBEE CLINTON
Purchase (P): 1,915,700 @ $2.61EDGAR
2025-08-014Prime Medicine, Inc. (PRME)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., CRANDELL KEITH, Burow Kristina
Purchase (P): 3,030,300 @ $3.30EDGAR
2025-02-034Metsera, Inc. (MTSR)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, NELSEN ROBERT
Conversion (C): 16,006,949 · Conversion (C): 7,523,682 · Purchase (P): 1,432,224 @ $18 · Purchase (P): 789,998 @ $18 · Conversion (C): 19,933,333 (derivative) · Conversion (C): 15,000,000 (derivative) · +3 moreEDGAR
2024-06-104Rapport Therapeutics, Inc. (RAPP)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina
Conversion (C): 3,728,738 @ $0 · Conversion (C): 20,000,000 (derivative) @ $0 · Conversion (C): 11,924,138 (derivative) @ $0EDGAR
2024-04-044Boundless Bio, Inc. (BOLD)
jointly with CRANDELL KEITH, BYBEE CLINTON, NELSEN ROBERT
Conversion (C): 589,743 · Conversion (C): 787,545 · Conversion (C): 1,048,433 · Purchase (P): 66,667 @ $16 · Purchase (P): 133,333 @ $16 · Conversion (C): 424,908 (derivative) · +6 moreEDGAR
2024-02-204Prime Medicine, Inc. (PRME)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., CRANDELL KEITH, Burow Kristina
Purchase (P): 3,200,000 @ $6.25EDGAR
2024-02-124Sana Biotechnology, Inc. (SANA)
jointly with CRANDELL KEITH, BYBEE CLINTON, Burow Kristina
Purchase (P): 363,637 @ $5.50 · Purchase (P): 727,272 @ $5.50 · Purchase (P): 727,272 @ $5.50EDGAR
2023-12-124Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, BYBEE CLINTON
Other (J): 703,061 · Other (J): 1,176,593EDGAR
2023-11-154Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 31,653 @ $11.75 · Purchase (P): 3,357 @ $11.98EDGAR
2023-11-134Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 69,127 @ $10.78 · Purchase (P): 23,124 @ $11.79 · Purchase (P): 31,079 @ $10.53 · Purchase (P): 11,844 @ $11.37 · Purchase (P): 5,431 @ $11.75EDGAR
2023-11-074Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 22,420 @ $11.38 · Purchase (P): 43,082 @ $11.55 · Purchase (P): 30,192 @ $11.50EDGAR
2023-09-294Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 16,841 @ $13.06 · Purchase (P): 25,110 @ $13.69 · Purchase (P): 34,560 @ $13.98EDGAR
2023-09-274Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 34,000 @ $11.73 · Purchase (P): 24,504 @ $12.31EDGAR
2023-09-254Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT
Purchase (P): 40,000 @ $11.14 · Purchase (P): 30,773 @ $10.80 · Purchase (P): 29,967 @ $11.65EDGAR
2023-09-204Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, NELSEN ROBERT, BYBEE CLINTON
Conversion (C): 684,167 · Conversion (C): 1,144,973 · Conversion (C): 6,895,021 · Conversion (C): 6,576,400 · Conversion (C): 2,124,143 · Purchase (P): 1,500,000 @ $17 · +5 moreEDGAR
2023-08-104DA32 Life Science Tech Acquisition Corp. (DALS)
jointly with ARCH Venture Fund XI, L.P., ARCH Venture Partners XI, L.P., ARCH Venture Partners XI, LLC, NELSEN ROBERT, Burow Kristina
Other (J): 1,600,000EDGAR
2023-07-284VBI Vaccines Inc/BC (VBIV)Grant/award (A): 52,500 (derivative) @ $0EDGAR
2023-07-184VBI Vaccines Inc/BC (VBIV)Purchase (P): 609,090 @ $1.65 · Purchase (P): 609,090 (derivative)EDGAR
2023-06-154Homology Medicines, Inc. (FIXX)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2023-02-214Codiak BioSciences, Inc. (CDAK)Option exercise (M): 8,750 · Option exercise (M): 8,750 (derivative) @ $0EDGAR
2023-01-304VBI Vaccines Inc/BC (VBIV)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-10-264Prime Medicine, Inc. (PRME)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., CRANDELL KEITH, Burow Kristina
Conversion (C): 5,728,297 · Conversion (C): 5,728,297 · Purchase (P): 400,000 @ $17 · Purchase (P): 400,000 @ $17 · Conversion (C): 16,666,667 (derivative) @ $0 · Conversion (C): 16,666,664 (derivative) @ $0 · +2 moreEDGAR
2022-09-154Codiak BioSciences, Inc. (CDAK)Purchase (P): 5,000,000 · Purchase (P): 5,000,000 (derivative)EDGAR
2022-06-214Codiak BioSciences, Inc. (CDAK)Grant/award (A): 7,500 (derivative) @ $0 · Grant/award (A): 1,500 (derivative) @ $0EDGAR
2022-06-174Homology Medicines, Inc. (FIXX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2022-02-184Codiak BioSciences, Inc. (CDAK)Grant/award (A): 8,750 (derivative) @ $0EDGAR
2022-01-314VBI Vaccines Inc/BC (VBIV)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-08-094DA32 Life Science Tech Acquisition Corp. (DALS)
jointly with ARCH Venture Fund XI, L.P., ARCH Venture Partners XI, L.P., ARCH Venture Partners XI, LLC, NELSEN ROBERT, Burow Kristina
Other (J): 701,250 (derivative) @ $0EDGAR
2021-08-034DA32 Life Science Tech Acquisition Corp. (DALS)
jointly with ARCH Venture Fund XI, L.P., ARCH Venture Partners XI, L.P., ARCH Venture Partners XI, LLC, NELSEN ROBERT, Burow Kristina
Purchase (P): 1,600,000 @ $10 · Other (J): 650,000 @ $10EDGAR
2021-07-204Erasca, Inc. (ERAS)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., NELSEN ROBERT, CRANDELL KEITH, Burow Kristina
Conversion (C): 5,527,777 · Conversion (C): 5,527,777 · Conversion (C): 2,100,000 (derivative) · Conversion (C): 2,100,000 (derivative) · Conversion (C): 3,400,000 (derivative) · Conversion (C): 1,133,333 (derivative) · +2 moreEDGAR
2021-06-234Verve Therapeutics, Inc. (VERV)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Fund X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners X, L.P., ARCH Venture Partners X Overage, L.P., CRANDELL KEITH, NELSEN ROBERT, Burow Kristina
Conversion (C): 1,254,404 · Conversion (C): 1,254,405 · Conversion (C): 7,107,024 (derivative) · Conversion (C): 7,107,023 (derivative) · Conversion (C): 4,508,144 (derivative) · Conversion (C): 4,508,146 (derivative)EDGAR
2021-06-224Homology Medicines, Inc. (FIXX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2021-06-224Codiak BioSciences, Inc. (CDAK)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-104Sana Biotechnology, Inc. (SANA)
jointly with ARCH Venture Fund X, L.P., CRANDELL KEITH, BYBEE CLINTON, Burow Kristina
Conversion (C): 10,156,250 · Conversion (C): 10,156,250 · Conversion (C): 11,718,750 · Conversion (C): 11,718,750 · Conversion (C): 3,687,500 (derivative) @ $0 · Conversion (C): 3,687,500 (derivative) @ $0 · +8 moreEDGAR
2021-01-294VBI Vaccines Inc/BC (VBIV)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2020-10-204Codiak BioSciences, Inc. (CDAK)Conversion (C): 1,784,572 · Conversion (C): 420,368 · Purchase (P): 235,000 @ $15 · Conversion (C): 13,950,000 (derivative) · Conversion (C): 3,000,000 (derivative)EDGAR
2020-10-154Codiak BioSciences, Inc. (CDAK)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2020-09-014Pulmatrix, Inc. (PULM)Disposition to issuer (D): 1,771 (derivative) · Grant/award (A): 1,771 (derivative) · Disposition to issuer (D): 111 (derivative) · Grant/award (A): 111 (derivative) · Disposition to issuer (D): 880 (derivative) · Grant/award (A): 880 (derivative) · +10 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1229592 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs